The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells.
Roth
Michael
M
Division of Pulmonary Cell Research, Department of Research, University Hospital Basel, Basel, Switzerland. rothmic@uhbs.ch
Tamm
Michael
M
D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000494:pharmacology*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D001706:Biopsy; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008297:Male; D008875:Middle Aged; D032389:Myocytes, Smooth Muscle / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D000069444:Omalizumab; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D020545:Respiratory Mucosa / Q000473:pathology
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D000069444:Omalizumab; D007073:Immunoglobulin E